Table of Contents: CATIE News - 2007
Canadian AIDS Treatment Information Exchange
Edited by: Sean Hosein

Table Of Contents

December
British Columbia—breaking barriers to hepatitis C care; IL-7­a potential immune booster makes its debut in Montreal; Alberta—HIV and pregnancy
November
PEP tested after sexual exposure to HIV in Los Angeles; Restless legs and HIV; Montreal researchers study HIV transmission; The perils of self-prescribing PEP; Ready, set and going on treatment; After LGV treatment—STIs return; Raltegravir approved in Canada
October
Kidney stones in some atazanavir users; Skin tumours appear despite HIV therapy; International study examines cervical health in HIV positive women; Atripla approved in Canada; Alberta – hepatitis B vaccine fails despite many attempts
September
Potential cancer-causing substance found in nelfinavir (Viracept); Refugee PHAs face many challenges to staying healthy; Superbug increasing among HIV positive people; Treatment interruptions increase risk for cancer; Maraviroc approved in Canada
August
Study looks at underlying causes of HIV, hepatitis C and substance use in Aboriginal youth; Cysteine supplement found to reduce desire for cocaine
July
CATIE Takes on Vital Hepatitis C Work; Adjusting methadone doses in some HAART users
June
Testosterone increase may depend on medications used; HIV medications and diabetes—is there a link?; Access to maraviroc in Canada; Tenofovir and the kidneys—safety analyses
April
Shifting risks for viral infections among some substance users; Montreal researchers make case for very early HIV treatment; Should HAART be used to reduce HIV transmission?; Study highlights complexity of HIV transmission issues; Access denied—liver transplants and HIV in Canada
March
Aboriginal Canadians being hit by hep C; Swedish lessons for Canada; Intriguing findings from study on lubricants
February
Testing for abacavir hypersensitivity in Canada; New guidelines for sexually transmitted infections in Canada
January
B.C. survey finds that some HIV positive women plan to have babies; Large U.S. study of pregnant women looks at HAART and birth defects
Copyright / Funding / How to reach CATIE
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980,2007. AEGiS . All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS , or the party credited as the provider of the content. Please contact the party credited as the provider of the content for permission to reproduce.